Thursday, August 21, 2014

Hot Quality Stocks To Invest In 2015

Business and consumer banking concern�Webster Financial� (NYSE: WBS  ) �announced yesterday that its board of directors has approved increasing its quarterly dividend by 50%, from�$0.10 per share to�$0.15 per share.�The new, higher payment�will be made on May 20 to stockholders of record as of May 6.

Webster also declared a regular quarterly cash dividend of $21.25 per share on its Series A Convertible Preferred Stock, payable on June 17 to shareholders of record on June 1.�On its Series E preferred stock, Webster declared a quarterly cash dividend of $400.00 per share, or $0.40 per each depositary share, 1,000 of which represent one share of Series E preferred stock. It will also be payable on June 17 to shareholders of record on June 1.

Webster Financial CEO James C. Smith cited "growth and quality of earnings and Webster's strong capital base."

Webster provides business and consumer banking, mortgages, financial planning, trust and investment services through 168 banking offices and has $20 billion in assets. The chart below does not include this week's dividend announcement.

Hot Quality Stocks To Invest In 2015: inContact Inc.(SAAS)

inContact, Inc. provides cloud-based contact center software services and network connectivity in the United States. Its solutions include inContact ACD, an automatic call distributor; inContact CTI, a computer telephony integration that integrates with customer data servers to provide agents pre-populated customer data; inContact IVR, an interactive voice response solution to create specialized call flows; and inContact Integrations for integration of various hardware and software solutions already in place at customer sites. The company also offers inContact ECHO that gathers the opinion of the customer and presents the analysis of the feedback directly to supervisors and agents; inContact Workforce Management, which forecasts demand, schedules workforce, analyzes and optimizes staffing, and reports real-time adherence in contact centers; inContact Quality Monitoring that provides insights into agent performance and customer satisfaction; and InContact Screen Recording, which provides compliance level screen recording functionality for voice channel interactions. In addition, it provides inContact eLearning that offers targeted, prioritized training, communications, and testing to the agent?s desktop during dips in call volumes; and inContact Network Connectivity, which includes time division multiplexing and voice over Internet protocol (VoIP) connectivity, and toll-free and local-number services. Further, inContact, Inc. offers professional services, as well as operates as a domestic and international long distance reseller and aggregator. The company was formerly known as UCN, Inc. and changed its name to inContact, Inc. in January 2009. inContact, Inc. was founded in 1994 and is headquartered in Salt Lake City, Utah.

Advisors' Opinion:
  • [By jaggom]

    Approximately 35% of the respondents cited that the internal or private cloud projects still dominated cloud-related activity. The public cloud services such as infrastructure as a service (IaaS) and software as a service (SaaS) activity in enterprises also doubled in the range of 30% and 33% in just the past six months.

  • [By Steve Symington]

    What:�Shares of inContact Inc. (NASDAQ: SAAS  ) rose more than 10% in Wednesday's early trading, and then gave back most of those gains to close up around 1% after the cloud contact center software provider released first-quarter results and announced an acquisition.

Hot Quality Stocks To Invest In 2015: American Residential Properties Inc (ARPI)

American Residential Properties, Inc., incorporated on March 30, 2012, is a fully integrated and internally managed real estate investment company, which is organized as a real estate investment trust. The Company acquires, renovates, leases and manages single-family properties in select communities nationally. The Company is operating in ten states. American Residential Properties OP, L.P. acts as its operating partnership. American Residential GP, LLC is the wholly owned subsidiary of the Company and the sole general partner of its operating partnership. American Residential Leasing Company, LLC is a wholly owned subsidiary of its operating partnership. American Residential Properties TRS, LLC (TRS), that is a wholly owned subsidiary of its operating partnership. As of March 31, 2013, it owned 2,531 properties in Arizona, California, Florida, Georgia, Illinois, Indiana, Nevada, North Carolina, South Carolina and Texas , and it managed an additional 608 properties for Phoenix Fund in Arizona and Nevada. For the period from April 1, 2013 to April 12, 2013, the Company acquired or have contracted to acquire 785 single-family homes, of which 43 homes are in Arizona, four homes are in California, 66 homes are in Florida, 25 homes are in Georgia, 35 homes are in Illinois, 114 homes are in Indiana, 214 homes are in North Carolina, nine homes are in South Carolina and 275 homes are in Texas.

In addition to the Company�� primary business strategy of acquiring, restoring, leasing and managing single-family homes, it has a private mortgage financing strategy. As of March 31, 2013, the Company�� total portfolio of single family homes included 1,045 homes in phoenix, 304 homes in Chicago, 209 homes in Inland Empire, 136 homes in Winston-Salem, 265 homes in Indianapolis, 78 homes in Dallas-Fort Worth, 169 homes in Atlanta, 82 homes in other-California, 63 homes in Las Vegas, 138 homes in Fort Myers, 24 homes in Houston, 6 homes in Raleigh-Cary, 11 homes in Charlotte and one home in Charleston. As! of March 31, 2013, the Company�� portfolio of self-managed single-family homes included 1,521 homes. As of March 31, 2013, the Company�� portfolio of preferred operator program single-family homes included 1,010 homes.

Advisors' Opinion:
  • [By Mark Holder]

    After an initial bump in Silver Bay, the stock has had a horrible 2013, now trading close to all-time lows. Recently, a couple of other IPOs in the sector have come to market with weak receptions. Both American Homes 4 Rent (NYSE: AMH  ) and American Residential Properties (NYSE: ARPI  ) offer different twists to the general thesis of investing in single-family rental properties to take advantage of the weakness in housing prices and the increased demand for rentals.

  • [By Amanda Alix]

    This spring, however, signs of a slowdown began to appear. The number of distressed properties began to diminish, prices began ticking upward, and interest rates started a slow rise. However, two snippets of good news may help float the boats of private equity firm Blackstone Group (NYSE: BX  ) , and single-family REITs Silver Bay (NYSE: SBY  ) and American Residential Properties (NYSE: ARPI  ) : easier credit, and higher foreclosure rates.

Best Oil Stocks To Invest In Right Now: Imagination Technologies Group PLC (IGNMF.PK)

Imagination Technologies Group plc is engaged in multimedia and communication technologies. The Company operates in two segments: Technology business and the Pure business. The Company�� Technology business segment is engaged in the development of embedded graphics, video, display and multi-threaded processor and multi-standard broadcast receiver and connectivity technologies for licensing to semiconductor companies for incorporation into silicon devices. The Company�� Pure business segment is engaged in the development and marketing of consumer products to showcase the technologies of the Technology business and to develop markets for such technologies. In March 2012, Toumaz Ltd completed the exchange of Imagination Technologies Group plc's interest in Toumaz Ltd�� Toumaz Microsystems subsidiary. In February 2013, it acquired the operating business and certain patent properties of MIPS Technologies, Inc. Advisors' Opinion:
  • [By Ashraf Eassa]

    However, I expect that Intel is at risk of having a significant marketing problem trying to sell a dual core product into a world of quad core phones, even if the dual core part delivers better performance/watt. I further expect that from what is currently known about Bay Trail's GPU (4 EU Gen7 GPU), it is unlikely that -- unless Intel is either using Imagination's (IGNMF.PK) next generation PowerVR 6 or a beefed up Gen7 design for the "Merrifield" SoC -- it will be as competitive with the Snapdragon 800 on the GPU side of things, which could pose as an additional headwind to adoption. I also believe that the Q1 2014 launch curtails any hope that there will be a 14nm smartphone product launched in 2014 (although Mr. Krzanich's comments about "acceleration" could be a source of optimism here), which means that the company's process lead could ultimately prove to be ephemeral in this particular end market. Fortunately, product cycles in this space are short, so it may be okay to have Merrifield be reasonably short lived.

Hot Quality Stocks To Invest In 2015: The Ultimate Software Group Inc.(ULTI)

The Ultimate Software Group, Inc., together with its subsidiaries, designs, develops, and markets unified human capital management software-as-a-service solutions to businesses in the United States and Canada. Its UltiPro software solution offers businesses with cloud-based functionality to manage the employment life cycle from recruitment to retirement. The UltiPro solution includes feature sets for talent acquisition and onboarding, human resource management and compliance, benefits management and online enrollment, payroll, performance management, salary planning and budgeting for compensation management, succession management, reporting and analytical decision-making tools, and time and attendance, as well as role-based access for executives, managers, administrators, and employees. The company offers its products and services for various industries, including manufacturing, food services, sports, technology, finance, insurance, retail, real estate, transportation, com munications, healthcare, and other services. It also provides implementation, training, maintenance, and technical support services. The Ultimate Software Group, Inc. markets its products under the UltiPro Enterprise and UltiPro Workplace brand names through its direct sales teams. The company was founded in 1990 and is headquartered in Weston, Florida.

Advisors' Opinion:
  • [By Patricio Kehoe]

    The firm is currently Zacks Rank # 3 - Hold, and it also has a longer-term recommendation of ��utperfom�� For investors looking for a Zacks Rank # 1 ��Strong Buy, Dealertrack Technologies Inc (TRAK), Open Text Corporation (OTEX), Pegasystems Inc. (PEGA) Solera Holdings (SLH) or Ultimate Software Group Inc. (ULTI) could be the options.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Ultimate Software Group (Nasdaq: ULTI  ) , whose recent revenue and earnings are plotted below.

  • [By Jeremy Bowman]

    What: Shares of Ultimate Software (NASDAQ: ULTI  ) were screaming "Ultimate!" today, gaining as much as 17% after topping estimates in its quarterly report.

Hot Quality Stocks To Invest In 2015: Baxter International Inc. (BAX)

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It operates in three segments: BioScience, Medication Delivery, and Renal. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; intravenous nutrition products; infusion pumps; and inhalation anesthetics. It also offers products and services related to pha rmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease or irreversible kidney failure. It manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes product for hemodialysis, which is conducted in a hospital or clinic. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors? offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is based in Deerfield, Illinois.

Advisors' Opinion:
  • [By Monica Gerson]

    Baxter International (NYSE: BAX) is expected to report its Q1 earnings at $1.09 per share on revenue of $3.88 billion.

    The Sherwin-Williams Company (NYSE: SHW) is projected to report its Q1 earnings at $1.11 per share on revenue of $2.36 billion.

  • [By James Brumley]

    A couple of other key pharmaceutical stocks released their third quarter numbers early on in the current earnings season:�Baxter International�(BAX), and�Johnson & Johnson�(JNJ). While both are waist-deep in non-pharma businesses, they’re still worth a close look through the same pharmaceutical lens.

  • [By Holly LaFon]

    Performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment return and principal value will fluctuate so that an investor's shares, when redeemed, may be worth more or less than original cost. As stated in the current prospectus, the Fund�� Investor Class Share�� annual operating expense ratio (gross) is 1.28%. The Fund�� adviser has contractually agreed to waive a portion of its fee and/or reimburse Fund expenses to limit total annual operating expenses at 1.25%, which is in effect until October 31, 2015. Other share classes may vary. The Fund charges a 2.0% redemption fee on shares redeemed within six months of purchase. For the most recent month-end performance, please call (877)328-9437 or visit the Advisor�� website at www.auxierasset.com. The recent growth rate in the stock market has helped to produce short-term returns that are not typical and may not continue in the future.Spring 2014 Market CommentaryAuxier Focus Fund�� Investor Class returned a modest 0.25% for the quarter ended March 31, while Standard and Poor�� 500 Stock Index (S&P) rose 1.81%. The Fund ended the quarter with 70% in U.S. stocks, 16% foreign stocks, 1.7 % bonds and 12.3% cash. Since inception in 1999, the Fund�� equity exposure has averaged 72%. Our stockholdings in the healthcare industry generally gained for the quarter. But many of our multinational and foreign stocks were hurt by the threat of currency repercussions from geopolitical events in Russia and Ukraine. The foreign portion of the Fund is easily the most undervalued. Longer term, we see a very favorable risk/reward potential with our UK and European holdings. Some emerging market companies we follow are the cheapest in over twenty years. In allocating capital, we much prefer the gloom of down to flat markets and the corrective process that tempers exuberance. We remember that one of th

  • [By Shauna O'Brien]

    On Friday, healthcare company Baxter International Inc. (BAX) announced that it has finalized its acquisition of medical technology company Gambro AB.

    The acquisition will help Baxter’s long term growth in the healthcare industry and will expand its product and therapies portfolio. Baxter will also help grow Gambro’s international exposure by expanding into Latin American and Asia Pacific.

    The deal was worth about $3.9 billion and will be included in BAX’s third quarter and full year results.

    Robert L. Parkinson, Jr., chairman and chief executive officer of Baxter commented: “The combination of these two respected renal leaders – Baxter and Gambro – will enable Baxter to better serve healthcare providers and patients through a collective offering of innovative renal products and therapies.”

    “Together, we will advance the state of dialysis care for patients with kidney disease worldwide.”

    Baxter International shares were mostly flat during pre-market trading Friday. The stock is up 5% YTD.

Hot Quality Stocks To Invest In 2015: Abbott Laboratories(ABT)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company offers adult and pediatric pharmaceuticals for rheumatoid and psoriatic arthritis, ankylosing spondylitis, psoriasis, and Crohn's disease; dyslipidemia; HIV infection; prostate cancer, endometriosis and central precocious puberty, and anemia caused by uterine fibroids; respiratory syncytial virus; adult males who have low or no testosterone; secondary hyperparathyroidism; hypothyroidism; and pancreatic exocrine insufficiency, as well as anesthesia products. It also provides diagnostic products, such as immunoassay systems; chemistry systems; assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological, and infectious diseases; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infections agents; genomic-b ased tests; hematology systems and reagents; and point-of-care diagnostic systems and tests for blood analysis. In addition, the company offers a line of pediatric and adult nutritional products. Further, it provides coronary, endovascular, vessel closure, and structural heart devices, such as drug-eluting stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, vessel closure devices, carotid stent systems, percutaneous valve repair systems, and drug eluting bioresorbable vascular products. Additionally, the company provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products, as well as branded generic pharmaceutical products. Abbott primarily serves retailers, wholesalers, hospitals, and health care facilities. Abbott was founded in 1888 and is headquartered in Abbott Park, Illinois.

Advisors' Opinion:
  • [By Marc Bastow]

    Healthcare products and pharmaceuticals manufacturer Abbott Laboratories (ABT) raised its quarterly dividend 57% to 22 cents per share, payable Feb. 15, 2014, to shareholders of record as of Jan. 15. This is the 42nd consecutive annual increase in ABT’s dividend.
    ABT Dividend Yield: 2.37%

  • [By Brian Orelli]

    After completing a $5 billion buyback program started late 2008, Abbott Labs (NYSE: ABT  ) is ready to buy another $3 billion worth of Abbott Laboratories stock.

  • [By Brian Orelli]

    AbbVie (NYSE: ABT  ) is the only pure pharma in the Dividend Aristocrats club, which requires 25 consecutive years of dividend increases. The six-month-old company is in the index because it spun out of Abbott Labs (NYSE: ABT  ) , which was in the index before the split. Even Abbott technically cut its dividend because it lost a substantial amount of its cash flow from AbbVie's drug. Still, I think the S&P let them stay in the index�simply because there are so few health care companies in the Dividend Aristocrats.

  • [By Gaurab Chakrabarti]

    One of the biggest players in HIV therapy is actually a joint venture between Pfizer (NYSE: PFE  ) �and GlaxoSmithKline (NYSE: GSK  ) �called Viiv Healthcare. Viiv Healthcare developed lamivudine and zidovudine, two of the most commonly used drugs for HIV therapy and part of multiple drug cocktails: Combivir, �Zeffix, Epirvir, and Trizivir to name a few. In total, ViiV has 11 marketed HIV drugs that all have a similar mechanism of action, that is, attacking aspects of the HIV virus. Abbott Laboratories (NYSE: ABT  ) is a another significant player in this market with their lopinavir and ritonavir combination drug, Kaletra patented through 2016. Kaletra sales generated $763 million in Q1-Q3 2012 which was down from $882 million in 2011, due to the quadrupling in price of ritonavir. Like ViiV, Abbott's Kaletra works on the premise of attacking the biology of the HIV virus. �

Hot Quality Stocks To Invest In 2015: WageWorks Inc (WAGE)

WageWorks, Inc., incorporated on January 28, 2000, is an on-demand provider of tax-advantaged programs for consumer-directed health, commuter and other employee spending account benefits (CDBs), in the United States. The Company administers and operates a broad array of CDBs, including spending account management programs such as health and dependent care Flexible Spending Accounts (FSAs), Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs), and commuter benefits, such as transit and parking programs. The Company delivers its CDB programs through a scalable delivery model that employer clients and their employee participants may access through a standard Web browser on any Internet-enabled device, including computers, smart phones and other mobile devices such as tablet computers. In January 2013, the Company acquired Benefit Concepts, Inc.

The Company focuses on providing CDB programs to employer clients of any size. It provides marketing programs that are designed to maxmize employee participation in its employer clients��CDB offerings. The Company markets and sells its CDB programs through multiple channels, including direct sales to enterprises, direct sales and through brokers to small and medium-sized businesses (SMBs), and direct sales to industry purchasing and affiliate groups and through channel partners.

Its SMB distribution channel complements its enterprise sales channel and consists of third party advisors, including insurance agents and benefits consultants who typically have two to three enterprise clients and several hundred smaller employer clients, and institutional resellers, including regional and national insurance carriers, health plans, payroll providers, commercial banks and third-party administrators (TPAs). The Company also sells its programs through group purchasing organizations in which the Company negotiate a standard service contract with group purchasing organizations that are formed by industry specific employers to cov! er their members.

The Company competes with TASC, Inc, Aetna, UHC, Aon Hewitt, ADP, Ceridian, CDBs and Bank of America.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on WageWorks (NYSE: WAGE  ) , whose recent revenue and earnings are plotted below.

  • [By John Udovich]

    On Wednesday, small cap employee flexible spending account facilitator Wageworks Inc (NYSE: WAGE) rose 12.22% despite a secondary offering that effectively rewarded insiders plus the stock has tripled since last March. However, Wageworks��CEO recently said in a�conference call last week that he believes the�private health care exchanges related to Obamacare are expanding�the company���market plus WAGE also raised its forecast for full-year growth. So�does that make this small cap a buy?�

  • [By Stock Gamer]

    WageWorks (WAGE) is a leading provider of tax-advantage programs for consumer-directed benefits ("CDBs") in the US. The company operates and administers a wide range of tax-advantage CDBs including health and dependent care Flexible Spending Accounts ("FSAs"), Healthy Savings Accounts ("HSAs"), Health Reimbursement Arrangements ("HRAs"), as well as commuter benefits. WageWorks' CBD programs allow employees to save tax money by using pre-tax earnings to pay for their healthcare and commuter expenses. The programs also enable employers to benefit from reduced payroll taxes as their contributions are deductible for tax purpose, even after factoring in WageWorks' service fees.

  • [By Laura Brodbeck]

    Tuesday

    Earnings Expected From: Frontier Communications Corporation (NASDAQ: FTR), GSI Group, Inc. (GSIG), Tesla Motors, Inc. (NASDAQ: TSLA), WageWorks, Inc. (NYSE: WAGE), DIRECTV (NASDAQ: DTV), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Economic Releases Expected: �Australian trade balance, New Zealand�� unemployment rate, Canadian trade balance, eurozone PPI, British services PMI

    Wednesday

Hot Quality Stocks To Invest In 2015: Stryker Corporation(SYK)

Stryker Corporation, together with its subsidiaries, operates as a medical technology company worldwide. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. The Reconstructive segment offers orthopaedic reconstructive (hip and knee) and trauma implant systems, as well as other related products. The MedSurg segment provides surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; and other related products. The Neurotechnology and Spine segment offers neurovascular products, spinal implant systems, and other related products. The company sells its products through local dealers and direct sales force to doctors, hospitals, and other healthcare facilities, as well as through third-party dealers and distributors in the United States, Europe, the Middle East, Africa, and Japan, Canada, the Pacific region, and the Latin America region. Stryker Corporat ion was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Advisors' Opinion:
  • [By James Brumley]

    At the extreme other end of the spectrum are medical device makers like Medtronics (MDT) and Stryker (SYK).

    These companies have already been crimped by Obamacare’s 2.3% excise tax (which went into effect at the beginning of this year) on certain medical devices in order to fund most of the act’s implementation. The tax reportedly costs the industry more than $2.5 billion per year, but medical device makers’ stocks are up a decent 13% since the end of 2012.

  • [By Sean Williams]

    Walking the fine line of full-time employment
    If middle-class individuals were working full time, this might not be as much of a problem, but job and hour cuts stemming from the upcoming implementation of Obamacare are becoming all too common. Surgical device maker Stryker (NYSE: SYK  ) �-- which would be expected to pay higher wages because of the specialization often required to work in the health care industry -- let go of 5% of its workforce in direct response to the higher costs associated with the PPACA and its 2.3% medical device excise tax.

  • [By Lauren Pollock]

    Stryker Corp.(SYK) agreed to acquire privately held surgical-equipment company Berchtold Holding AG for an enterprise value of $172 million. Berchtold, which has operations in Germany and the U.S., generated sales of roughly $125 million last year. The company’s products include surgical tables, equipment booms and surgical lighting systems.

  • [By Dan Carroll and Max Macaluso, Ph.D.]

    Buying into the Asian health-care scene isn't anything new. Stryker (NYSE: SYK  ) made waves earlier this year by purchasing Chinese spine and trauma firm Trauson for $764 million, and with China's health-care industry still in a state of transition, this is a potent grow opportunity for device firms. But is Panasonic's business worth all that much to buyers? Motley Fool contributor Dan Carroll and health-care analyst Max Macaluso discuss what you need to know in the following video.

Hot Quality Stocks To Invest In 2015: Nyxio Technologies Corp (NYXO)

Nyxio Technologies Corporation, incorporated on June 08, 2006, through its wholly owned subsidiary Nyxio Technologies Inc. (Nyxio), develop and provide technology for the entertainment and commercial markets within the consumer electronic industry. The Company�� product includes VioSphere Smart television (TV), a flat screen TV with a fully integrated personal computer.

The Realm is an all in one personal computer (PC)/ TV, combining the latest in PC technology with high definition (HD) TV. The Realm Pro, which is all in One PC/TV geared for commercial and digital signage markets. Venture MMV, which is a mobile media viewer is a new class of video eyewear offering designer styling in a sleek ergonomic design with features and performance. The Vuzion is a TV with Android operating system (OS) built in enabling 400,000 Android applications on a TV.

The Company competes with Sony, Samsung, LG, Vizio, Apple, Dell, and HP.

Advisors' Opinion:
  • [By Peter Graham]

    Nyxio Technologies Corp (OTCMKTS: NYXO), COREwafer Industries Inc (OTCMKTS: WAFR) and NanoTech Entertainment, Inc (OTCMKTS: NTEK) are three small cap stocks in some very diverse industries. In fact, one of these stocks just bought a 3D ice sculpture business. So will investors see their investment melt with that small cap stock�along with the other two? Here is a closer look to help you decide for yourself:��

No comments:

Post a Comment